Given that small molecule inhibitors of GSK3B and activators of AKT1 have been reported to possess protective effects in experimental models of PD (48, 53), fisetin could be a promising neuroprotective agent for PD due to its ability to inhibit GSK3B or activate AKT1. This evidence concerns the gene AKT1 and Parkinson disease.